| #80 |
Phillips Eifion |
Astrazeneca Ab |
1 |
| #80 |
Frank P. Tise |
Hercules |
1 |
| #80 |
Gabriel Sung |
University Technologies International |
1 |
| #80 |
Randy M. McCormick |
Aclara Biosciences |
1 |
| #80 |
Andris Suna |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Ronald R Luongo |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Patrick M. Burke |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Rex L. Beaton |
— |
1 |
| #80 |
Robert G. Pembleton |
E.I. Du Pont De Nemours And |
1 |
| #80 |
James B. Ganci |
Ciba-Geigy |
1 |
| #80 |
Bruce D. Korant |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Chi-Kai Shih |
E.I. Du Pont De Nemours And |
1 |
| #80 |
John Byrne Michel |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Jeannine M. Hollis |
Bristol-Myers Squibb |
1 |
| #80 |
Roger Song |
Conocophillips |
1 |
| #80 |
Ronald Mattson |
Conocophillips |
1 |
| #80 |
J. Rafalski |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Paul J. Fischer |
W.L. Gore & Associates Gmbh |
1 |
| #80 |
Mookkan Periyasamy |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Charles Cook |
Occidental Chemical |
1 |
| #80 |
Douglas J. Adelman |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Alan Martin Allgeier |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Michael J. McCarthy |
Optum Services (Ireland) Limited |
1 |
| #80 |
Nazeer A. Bhore |
ExxonMobil |
1 |
| #80 |
Robert Daniel Lousenberg |
The Chemours Company Fc |
1 |
| #80 |
John Ronald Boyles |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Petrus Fredericus Wilhelmus Stouten |
Dupont Pharmaceuticals |
1 |
| #80 |
Elliot P. Hertzenberg |
Pq |
1 |
| #80 |
Kenneth R. Tarburton |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Robert J. Furmanak |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Edward McDonald Huie |
Osi Pharmaceuticals |
1 |
| #80 |
Dujie Qin |
Anp Technologies |
1 |
| #80 |
Michael G. Mauk |
University of Pennsylvania |
1 |
| #80 |
Joseph So |
Rohm And Haas Electronic Materials Cmp Holdings |
1 |
| #80 |
Michael McGuinness |
Verizon |
1 |
| #80 |
Todd Andrew Brugel |
The Procter & Gamble |
1 |
| #80 |
Theodore M. Klein |
Pioneer (Corteva) |
1 |
| #80 |
Timothy Piser |
Astrazeneca Ab |
1 |
| #80 |
Gongyao Zhou |
Drexel University |
1 |
| #80 |
Taracad Venkatachalam |
Parker Hughes Institute |
1 |
| #80 |
Sami Khan |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Samuel A. Thompson |
Hercules |
1 |
| #80 |
Lisa A. Laffend |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Jerome David Smith |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Garret D. Figuly |
E.I. Du Pont De Nemours And |
1 |
| #80 |
James Michael Garner |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Douglas G. Batt |
Bristol-Myers Squibb |
1 |
| #80 |
Kristy Kostichka |
E.I. Du Pont De Nemours And |
1 |
| #80 |
Daniel D. Friel, Sr. |
Edgecraft |
1 |
| #80 |
Juan Carlos Figueroa |
E.I. Du Pont De Nemours And |
1 |